A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS). - Related Studies

A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).

This study is ongoing, but not recruiting participants.

Study NCT00000393. Last updated on June 23, 2005. Information provided by National Institute of Mental Health (NIMH)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		HIV Infections
		Cognition Disorders

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Immunologic Deficiency Syndromes
		Infection

3	More general conditions related to this trial
		Delirium, Dementia, Amnestic, Cognitive Disorders
		Immune System Diseases
		Lentivirus Infections
		Mental Disorders
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Slow Virus Diseases
		Virus Diseases

4	Interventions listed in this trial
		Peptide T

5	Sponsors listed in this trial
		National Institute of Mental Health (NIMH)